FDG-PET/CT-based restaging may alter initial management decisions and clinical outcomes in patients with locally advanced pancreatic carcinoma planned to undergo chemoradiotherapy.
about
FDG-PET/CT-based restaging may alter initial management decisions and clinical outcomes in patients with locally advanced pancreatic carcinoma planned to undergo chemoradiotherapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
FDG-PET/CT-based restaging may ...... to undergo chemoradiotherapy.
@en
FDG-PET/CT-based restaging may ...... to undergo chemoradiotherapy.
@nl
type
label
FDG-PET/CT-based restaging may ...... to undergo chemoradiotherapy.
@en
FDG-PET/CT-based restaging may ...... to undergo chemoradiotherapy.
@nl
prefLabel
FDG-PET/CT-based restaging may ...... to undergo chemoradiotherapy.
@en
FDG-PET/CT-based restaging may ...... to undergo chemoradiotherapy.
@nl
P2860
P1433
P1476
FDG-PET/CT-based restaging may ...... to undergo chemoradiotherapy.
@en
P2093
Ali Fuat Yapar
Erkan Topkan
P2860
P304
P356
10.1102/1470-7330.2013.0035
P50
P577
2013-10-04T00:00:00Z